TELA Bio, Inc.
TELA
$0.57
-$0.05-8.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.81% | 17.06% | 21.25% | -98.98% | 28.56% |
| Total Depreciation and Amortization | -15.41% | -5.70% | 8.43% | 14.10% | 65.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.63% | 11.22% | -11.70% | 131.97% | 37.94% |
| Change in Net Operating Assets | 208.63% | 176.53% | 307.78% | 81.72% | -866.97% |
| Cash from Operations | 35.33% | 36.34% | 26.10% | 32.39% | 31.85% |
| Capital Expenditure | 65.53% | -72.95% | 61.87% | 89.47% | -28.78% |
| Sale of Property, Plant, and Equipment | 282.43% | -- | -13.11% | -96.60% | 516.67% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 201.05% | 355.74% | 204.48% | -97.06% | 1.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -72.45% | -61.54% | -100.00% | -84.11% | 164,973.08% |
| Repurchase of Common Stock | 63.64% | -10.53% | 72.73% | 46.04% | -175.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -39.77% | -75.51% | 40.00% | -307.14% | 194,936.36% |
| Foreign Exchange rate Adjustments | -119.23% | 155.32% | -1,166.67% | -391.30% | 1,200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -40.25% | 42.59% | 26.21% | -2.62% | 415.57% |